KRAS G12C inhibitors and methods of using the same
US11045484B2 · kind B2 · utility
19Cited by
46References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2019 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | May 3, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.